APIS Assay Technologies
Pre-clinicalChemically modified aptamers (Clickmers) for use as therapeutic candidates, research tools, and in diagnostic assays
Founded
2014
Focus
Diagnostics
About
Chemically modified aptamers (Clickmers) for use as therapeutic candidates, research tools, and in diagnostic assays
Funding History
1Total raised: $1.2M
Seed$1.2MUndisclosedMar 15, 2021
Company Info
TypePrivate
Founded2014
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile